Osteopathic Manipulative Treatment and Migraine Headaches
Unknown statusNot applicableNCT04976985
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this study the investigators hypothesize, that Osteopathic Manipulative Therapy (OMT) will reduce migraine disability and severity scores when compared to standard of care including prophylactic pharmacological agents with treatment over 12 week time frame. The investigators aim to decrease severity and disability of migraine by utilizing Osteopathic Manipulative Therapy. This would ultimately reduce the utilization of office or emergency department visits, decrease the large economic burden the United States faces for migraine patients as well as improve quality of life for the 3 million chronic migraine patients.
Study details
- Official title
- The Efficacy of Osteopathic Manipulative Treatment on Decreasing the Severity of Migraine Headaches
- Conditions
- Chronic Migraine
- Migraine Disorders
- Headache Disorders
- Headache, Migraine
- Interventions
- Procedure: Osteopathic Manipulative Therapy (OMT)
- Other: Standard of care
- Sponsor
- St. Luke's Hospital, Pennsylvania
- Start date
- 2018-10-02
- Primary completion
- 2022-03-30
- Sex
- All
- Age range
- from 18 Years to 50 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age: 18-50 2. Gender: Male and Female 3. ICD 10 code of migraine with or without aura (G43.0, G43.1, G43.70, G43.71) 4. No change in prophylactic medication for both control and intervention group 5. No physical therapy for headaches, neck pain or for trapezius muscle during 12 weeks for both control and intervention group Exclusion Criteria: 1. Previous Surgery to neck or cranium, history of previous stroke 2. More than two daily prophylactic pharmacologic agents used for the indication of Migraine headache 3. Active cancer 4. Receiving BOTOX® for migraines or treatment within the last 4 months 5. If patient has contraindications for OMT for the intervention group such as clinical signs of fractures in cervical spine, ligament instability, or severe vertebral artery stenosis 6. If patient is poor candidate for OMT in intervention group such as the patient is unable to follow commands. 7. Seizure disorder or recent head trauma 8. Pregnant or become pregnant during the treatment period
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04976985